Inhaled antibiotic therapy

M. Loebinger (London, United Kingdom)

Source: Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections
Session: PG9 How to optimise antibiotic use in respiratory infections
Session type: Postgraduate Course
Number: 28
Disease area: Respiratory infections

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Loebinger (London, United Kingdom). Inhaled antibiotic therapy. Annual Congress 2013 –PG9 How to optimise antibiotic use in respiratory infections

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral vs. inhaled antibiotic therapy
Source: International Congress 2015 – Bronchiectasis in Europe: an update from the European Bronchiectasis Network (EMBARC)
Year: 2015



Inhaled antibiotic therapy in patients with severe asthma
Source: Virtual Congress 2021 – Advances in asthma treatment
Year: 2021


Co-dispensing of inhaled corticosteroids and antibiotics
Source: Annual Congress 2012 - Effectiveness of therapeutic interventions in primary care
Year: 2012

Inhaled corticosteroids as a cause of CAP
Source: Eur Respir Monogr 2014; 63: 234-242
Year: 2014


Inhaled corticosteroids: a controversial add-on treatment in COPD
Source: Eur Respir J 2010; 36: 973-974
Year: 2010


Inhaled antibiotics in critical care
Source: Eur Respir Monogr 2017; 75: 80-96
Year: 2017


Inhaled corticosteroids in the treatment of acute asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 305s
Year: 2002

NIV and inhaled therapy
Source: International Congress 2014 – Two are better than one? Endorsement of noninvasive ventilation (NIV)
Year: 2014



Inhaled steroids and COPD
Source: Eur Respir J 2008; 32: 523-524
Year: 2008


Patterns of adherence to inhaled corticosteroids
Source: International Congress 2019 – Inhalers: adherence and preference
Year: 2019

Impact of the combination therapy: inhaled corticosteroid and long-acting beta agonists in the prescription pattern of inhaled corticosteroids
Source: Annual Congress 2007 - Respiratory issues in primary care
Year: 2007


Inhaled steroids in the treatment of newly detected asthma
Source: Eur Respir J 2004; 24: Suppl. 48, 124s
Year: 2004

Efficacy and safety of high-dose inhaled corticosteroids therapy in children with asthma
Source: Annual Congress 2010 - Allergy and risk factors in paediatrics
Year: 2010


Inhaled therapy reduces COPD mortality
Source: ERJ Open Res, 6 (4) 00634-2020; 10.1183/23120541.00634-2020
Year: 2020



Inhaled therapy in cystic fibrosis: agents, devices and regimens
Source: Breathe 2015; 11:110-118
Year: 2015



Inhaled antibiotics in chronic airway infections
Source: Eur Respir Monogr 2017; 75: 57-79
Year: 2017


Inhaled corticosteroid containing combinations and mortality in COPD
Source: Eur Respir J, 52 (6) 1801230; 10.1183/13993003.01230-2018
Year: 2018



Long-term antibiotic therapy
Source: International Congress 2017 – PG3 Bronchiectasis
Year: 2017


Inhaled antibiotics in ventilator-associated pneumonia: treatment or prophylaxis?
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016